Objective: To examine the relationship between neuropsychological impairment and antipho-spholipid antibody syndrome (aPL syndrome) in patients with systemic lupus erythermatosus (SLE). Patients: Sixty-nine patients satisfying ACR criteria were studied. Sixteen patients with the aPL syndrome and 53 patients without the syndrome were subjected to eight neuropsychological tests, a physical examination and serological investigations. No patients with other pathology, known to cause acute or chronic impairment of neuropsychological function, were included. Sixty-five underwent MRI scans. Results: There were no significant differences in age, level of education, incidence of hypertension or disease activity in the two groups. Pearson’s correlati...
BACKGROUND: Different pathogenetic pathways have been proposed for neuropsychiatric (NP) manifestati...
Background: Different pathogenetic pathways have been proposed for neuropsychiatric (NP) manifestati...
Objectives: To determine the prevalence of cognitive dysfunction in SLE patients with overt neuropsy...
To access publisher full text version of this article. Please click on the hyperlink in Additional L...
Background: Systemic Lupus Erythematosus (SLE) is an autoimmune disease encompassing a wide range of...
Antiphospholipid antibodies (aPL) are well-known risk factors for venous and arterial thrombosis, bu...
Systemic lupus erythematosus (SLE) is an autoimmune disease that affects mostly women of child-beari...
To access publisher full text version of this article. Please click on the hyperlink in Additional L...
To access publisher full text version of this article. Please click on the hyperlink in Additional L...
Introduction: Systemic lupus erythematosus (SLE) is characterized by frequent neuropsychiatric invol...
Objective The aim of this study was to compare the cognitive function of antiphospholipid antibody (...
Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Cognitive disorders have frequen...
SLE is associated with neuropsychiatric (NP) symptoms. The roles of various genotypes and autoantibo...
OBJECTIVES: Cognitive dysfunction is common in patients with antiphospholipid antibodies (aPL) (incl...
Session: P05 Epidemiology and clinical research: Poster presentationBackground: Studies on cognitive...
BACKGROUND: Different pathogenetic pathways have been proposed for neuropsychiatric (NP) manifestati...
Background: Different pathogenetic pathways have been proposed for neuropsychiatric (NP) manifestati...
Objectives: To determine the prevalence of cognitive dysfunction in SLE patients with overt neuropsy...
To access publisher full text version of this article. Please click on the hyperlink in Additional L...
Background: Systemic Lupus Erythematosus (SLE) is an autoimmune disease encompassing a wide range of...
Antiphospholipid antibodies (aPL) are well-known risk factors for venous and arterial thrombosis, bu...
Systemic lupus erythematosus (SLE) is an autoimmune disease that affects mostly women of child-beari...
To access publisher full text version of this article. Please click on the hyperlink in Additional L...
To access publisher full text version of this article. Please click on the hyperlink in Additional L...
Introduction: Systemic lupus erythematosus (SLE) is characterized by frequent neuropsychiatric invol...
Objective The aim of this study was to compare the cognitive function of antiphospholipid antibody (...
Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Cognitive disorders have frequen...
SLE is associated with neuropsychiatric (NP) symptoms. The roles of various genotypes and autoantibo...
OBJECTIVES: Cognitive dysfunction is common in patients with antiphospholipid antibodies (aPL) (incl...
Session: P05 Epidemiology and clinical research: Poster presentationBackground: Studies on cognitive...
BACKGROUND: Different pathogenetic pathways have been proposed for neuropsychiatric (NP) manifestati...
Background: Different pathogenetic pathways have been proposed for neuropsychiatric (NP) manifestati...
Objectives: To determine the prevalence of cognitive dysfunction in SLE patients with overt neuropsy...